Literature DB >> 15048551

Terlipressin in patients with septic shock: friend or foe?

M Westphal, C Ertmer, H Van Aken, H-G Bone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048551     DOI: 10.1007/s00134-004-2243-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

Review 1.  Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis.

Authors:  J H James; F A Luchette; F D McCarter; J E Fischer
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

2.  Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.

Authors:  Martin Westphal; Henning Stubbe; Andreas Wilhelm Sielenkämper; Reka Borgulya; Hugo Van Aken; Christian Ball; Hans-Georg Bone
Journal:  Intensive Care Med       Date:  2002-11-30       Impact factor: 17.440

3.  Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.

Authors:  Andrea Morelli; Monica Rocco; Giorgio Conti; Alessandra Orecchioni; Andrea De Gaetano; Giuliana Cortese; Flaminia Coluzzi; Enrico Vernaglione; Paolo Pelaia; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

Review 4.  The International Sepsis Forum's frontiers in sepsis: High cardiac output should be maintained in severe sepsis.

Authors:  Jean-Louis Vincent
Journal:  Crit Care       Date:  2003-07-04       Impact factor: 9.097

  4 in total
  2 in total

Review 1.  Alcohol abuse and the injured host: dysregulation of counterregulatory mechanisms review.

Authors:  Patricia E Molina; Jesse K Sulzer; Annie M Whitaker
Journal:  Shock       Date:  2013-03       Impact factor: 3.454

Review 2.  [Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].

Authors:  C Ertmer; A W Sielenkämper; H van Aken; H-G Bone; M Westphal
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.